Empowered Funds LLC Acquires 13,409 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Empowered Funds LLC raised its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS) by 8.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 177,554 shares of the company’s stock after purchasing an additional 13,409 shares during the quarter. Empowered Funds LLC’s holdings in Avanos Medical were worth $3,535,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Westwood Holdings Group Inc. increased its stake in shares of Avanos Medical by 2.0% during the fourth quarter. Westwood Holdings Group Inc. now owns 2,151,091 shares of the company’s stock valued at $48,249,000 after buying an additional 41,818 shares during the period. Tributary Capital Management LLC increased its stake in shares of Avanos Medical by 7.5% during the first quarter. Tributary Capital Management LLC now owns 742,455 shares of the company’s stock valued at $14,782,000 after buying an additional 51,865 shares during the period. Alberta Investment Management Corp increased its stake in shares of Avanos Medical by 16.6% during the fourth quarter. Alberta Investment Management Corp now owns 413,418 shares of the company’s stock valued at $9,273,000 after buying an additional 58,826 shares during the period. Foundry Partners LLC increased its stake in shares of Avanos Medical by 74.6% during the fourth quarter. Foundry Partners LLC now owns 371,029 shares of the company’s stock valued at $8,322,000 after buying an additional 158,473 shares during the period. Finally, Norges Bank purchased a new position in shares of Avanos Medical during the fourth quarter valued at $7,016,000. 95.17% of the stock is currently owned by institutional investors.

Avanos Medical Trading Down 0.5 %

NYSE AVNS traded down $0.10 during trading on Friday, hitting $21.08. The company’s stock had a trading volume of 213,220 shares, compared to its average volume of 214,525. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.28 and a quick ratio of 1.47. The business’s 50 day simple moving average is $19.78 and its 200-day simple moving average is $19.55. Avanos Medical, Inc. has a fifty-two week low of $17.24 and a fifty-two week high of $26.56.

Avanos Medical (NYSE:AVNS) last released its earnings results on Thursday, May 2nd. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.02). Avanos Medical had a positive return on equity of 4.10% and a negative net margin of 9.15%. The firm had revenue of $166.10 million for the quarter, compared to analyst estimates of $162.90 million. During the same period last year, the firm earned $0.27 EPS. The company’s revenue for the quarter was up 4.3% compared to the same quarter last year. On average, analysts anticipate that Avanos Medical, Inc. will post 1.38 EPS for the current year.

Analyst Ratings Changes

AVNS has been the topic of several research reports. StockNews.com upgraded Avanos Medical from a “hold” rating to a “buy” rating in a research note on Saturday, May 11th. JMP Securities reissued a “market perform” rating on shares of Avanos Medical in a report on Tuesday, May 7th.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.